This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Are Options Traders Betting on a Big Move in Adient (ADNT) Stock?
by Zacks Equity Research
Investors need to pay close attention to Adient (ADNT) stock based on the movements in the options market lately.
New Strong Sell Stocks for November 15th
by Zacks Equity Research
ADNT, WMS and BATRA have been added to the Zacks Rank #5 (Strong Sell) List on November 15, 2024.
Adient Q4 Earnings Surpass Expectations, Revenues Decline Y/Y
by Zacks Equity Research
ADNT reports better-than-expected Q4 results and expects fiscal 2025 revenues in the range of $14.1-$14.4 billion, down from $14.69 billion reported in 2024.
Adient (ADNT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Adient (ADNT) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Adient (ADNT) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of 21.43% and 2.25%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Adient (ADNT) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Adient (ADNT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024.
OPENLANE (KAR) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
OPENLANE (KAR) delivered earnings and revenue surprises of 23.81% and 2.21%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Adient (ADNT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Adient Gains From Diverse Customer Base, Faces Competition
by Zacks Equity Research
While ADNT's diverse customer base and international presence strengthen its market position, rising competition remains a concern.
Adient (ADNT) Up 3.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Adient (ADNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Adient (ADNT) Q3 Earnings Miss Estimates, Guidance Trimmed
by Zacks Equity Research
Adient (ADNT) reports lower-than-expected fiscal third-quarter results and expects fiscal 2024 revenues to be $14.6 billion, down from the previous guidance of $14.80-$14.90 billion.
Compared to Estimates, Adient (ADNT) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Adient (ADNT) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Adient (ADNT) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of -52.24% and 2.53%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Dana (DAN) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Dana (DAN) delivered earnings and revenue surprises of 29.17% and 1.66%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Adient (ADNT) Q3 Earnings Expected to Decline
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for July 1st
by Zacks Equity Research
ADNT, ARCB and GEO have been added to the Zacks Rank #5 (Strong Sell) List on July 1, 2024.
New Strong Sell Stocks for June 25th
by Zacks Equity Research
ARR, ADNT and USAS have been added to the Zacks Rank #5 (Strong Sell) List on June 25, 2024.
Sunoco and Adient's have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Sunoco and Adient's are part of the Zacks Bull and Bear of the Day article.
Bear of the Day: Adient (ADNT)
by Shaun Pruitt
Investors hoping for a rebound in Adient's (ADNT) stock may be disappointed given the downward trend of earnings estimate revisions which still suggests more short-term weakness ahead
New Strong Sell Stocks for June 17th
by Zacks Equity Research
ADNT, ARCB and CIVB have been added to the Zacks Rank #5 (Strong Sell) List on June 17, 2024.
New Strong Sell Stocks for June 6th
by Zacks Equity Research
ADNT, CALB and CTRE have been added to the Zacks Rank #5 (Strong Sell) List on June 6, 2024.
New Strong Sell Stocks for June 3rd
by Zacks Equity Research
BOOT, CPRI and ADNT have been added to the Zacks Rank #5 (Strong Sell) List on June 3, 2024.
New Strong Sell Stocks for May 21st
by Zacks Equity Research
DDD, ADNT and ALGT have been added to the Zacks Rank #5 (Strong Sell) List on May 21, 2024.
Adient (ADNT) Q2 Earnings Beat Estimates, Guidance Revised
by Zacks Equity Research
Adient (ADNT) reports mixed fiscal second-quarter results and expects fiscal 2024 revenues in the range of $14.8-$14.9 billion, down from the previous guidance of $15.40-$15.50 billion.
New Strong Sell Stocks for May 13th
by Zacks Equity Research
AESI, AEG and ADNT have been added to the Zacks Rank #5 (Strong Sell) List on May 13, 2024.